Freshfields Sees Asia Alternatives Amid China M&A Drop
This article is for subscribers only.
Hi, it’s Manuel Baigorri and Will Davies in Hong Kong, where Sebastian Fain and Kenneth I. Juster of Freshfields sat down to chat about how deals in Japan and India are offsetting the slowdown in China—and how long that slowdown might last. Also today, PAI isn’t giving up on Sanofi’s OTC business.
Today's top stories